mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability

Genes and Development - Tập 18 Số 4 - Trang 423-434 - 2004
Christine Mayer1, Jian Zhao2, Xuejun Yuan2, Ingrid Grummt3
1Division of Molecular Biology of the Cell II, German Cancer Research Center, D-69120 Heidelberg, Germany
2German Cancer Research Center (dkfz
3Cell Biology and Tumor Biology

Tóm tắt

In cycling cells, transcription of ribosomal RNA genes by RNA polymerase I (Pol I) is tightly coordinated with cell growth. Here, we show that the mammalian target of rapamycin (mTOR) regulates Pol I transcription by modulating the activity of TIF-IA, a regulatory factor that senses nutrient and growth-factor availability. Inhibition of mTOR signaling by rapamycin inactivates TIF-IA and impairs transcription-initiation complex formation. Moreover, rapamycin treatment leads to translocation of TIF-IA into the cytoplasm. Rapamycin-mediated inactivation of TIF-IA is caused by hypophosphorylation of Ser 44 (S44) and hyperphosphorylation of Ser 199 (S199). Phosphorylation at these sites affects TIF-IA activity in opposite ways, for example, phosphorylation of S44 activates and S199 inactivates TIF-IA. The results identify a new target for mTOR-signaling pathways and elucidate the molecular mechanism underlying mTOR-dependent regulation of rRNA synthesis.

Từ khóa


Tài liệu tham khảo

1993, J. Biol. Chem., 268, 22825, 10.1016/S0021-9258(18)41602-X

10.1038/45287

10.1093/embo-reports/kvd032

10.1126/science.277.5322.99

10.1038/sj.onc.1202402

10.1073/pnas.95.4.1432

10.1093/nar/13.22.8165

10.1074/jbc.M201232200

10.1016/S0092-8674(00)81257-X

2003, Mol. Cell. Biol., 15, 946

10.1074/jbc.273.24.14845

10.1126/science.1063518

10.1101/gad.10.15.1904

10.1101/gad.887201

10.1101/gad.1098503R

10.1128/MCB.23.23.8862-8877.2003

10.1074/jbc.273.23.14484

10.1073/pnas.96.26.14866

10.1002/jcb.10135

10.1074/jbc.273.23.14424

10.1016/S0006-291X(02)03052-8

10.1074/jbc.274.48.34493

2003, Nat. Rev., 4, 117, 10.1038/nrm1018

10.1093/emboj/18.10.2782

1998, Blood, 91, 561, 10.1182/blood.V91.2.561

10.1016/S1097-2765(03)00114-X

1996, EMBO J., 15, 7060, 10.1002/j.1460-2075.1996.tb01097.x

10.1073/pnas.96.11.6096

2001, J. Nutrit., 131, 861, 10.1093/jn/131.3.861S

10.1016/0192-0561(94)90091-4

10.1093/emboj/17.13.3692

10.1093/emboj/20.6.1373

10.1073/pnas.080063997

10.1073/pnas.96.8.4438

1999, Mol. Biol. Cell, 104, 987

2002, Eur. J. Biochem., 269, 5338, 10.1046/j.1432-1033.2002.03292.x

10.1016/S0014-5793(97)00323-2

10.1016/S0092-8674(00)00117-3

10.1006/meth.1996.0030

1990, EMBO J., 9, 2857, 10.1002/j.1460-2075.1990.tb07475.x

10.1002/1615-9861(200207)2:7<911::AID-PROT911>3.0.CO;2-K

10.1515/BC.2001.146

10.1016/0092-8674(87)90514-9

10.1073/pnas.231071698

10.1093/emboj/18.7.1891

10.1074/jbc.M102776200

10.1074/jbc.274.45.31917

10.1093/embo-reports/kvf212

1998, Mol. Cell. Biol., 18, 4463, 10.1128/MCB.18.8.4463

10.1101/gad.835000

10.1016/S1097-2765(03)00036-4